- Home
- ESPR vs UFCS Comparison
ESPR vs UFCS Comparison
Compare ESPR & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESPR | UFCS |
|---|---|---|
| Founded | 2008 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 933.8M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESPR | UFCS |
|---|---|---|
| Price | $3.89 | $36.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.67 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 5.3M | 132.0K |
| Earning Date | 11-06-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | N/A | ★ 118.04 |
| EPS | N/A | ★ 4.24 |
| Revenue | $303,802,000.00 | ★ $1,353,781,000.00 |
| Revenue This Year | $26.11 | $10.11 |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | ★ N/A | $8.60 |
| Revenue Growth | 2.83 | ★ 12.12 |
| 52 Week Low | $0.69 | $24.11 |
| 52 Week High | $4.13 | $37.91 |
Technical Indicators
Market Signals| Indicator | ESPR | UFCS |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 53.77 |
| Support Level | $3.87 | $36.09 |
| Resistance Level | $4.05 | $37.91 |
| Average True Range (ATR) | 0.20 | 0.78 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 50.00 | 57.94 |
Price Performance
Historical ComparisonAbout ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.